Literature DB >> 29622701

The Role of Notch3 in Cancer.

Zviadi Aburjania1, Samuel Jang1, Jason Whitt1, Renata Jaskula-Stzul1, Herbert Chen1, J Bart Rose2.   

Abstract

The Notch family is a highly conserved gene group that regulates cell-cell interaction, embryogenesis, and tissue commitment. This review article focuses on the third Notch family subtype, Notch3. Regulation via Notch3 signaling was first implicated in vasculogenesis. However, more recent findings suggest that Notch3 signaling may play an important role in oncogenesis, tumor maintenance, and resistance to chemotherapy. Its role is mainly oncogenic, although in some cancers it appears to be tumor suppressive. Despite the wealth of published literature, it remains relatively underexplored and requires further research to shed more light on its role in cancer development, determine its tissue-specific function, and elaborate novel treatment strategies. Herein we summarize the role of Notch3 in cancer, possible mechanisms of its action, and current cancer treatment strategies targeting Notch3 signaling. IMPLICATIONS FOR PRACTICE: The Notch family is a highly conserved gene group that regulates cell-cell interaction, embryogenesis, and tissue commitment. This review summarizes the existing data on the third subtype of the Notch family, Notch3. The role of Notch3 in different types of cancers is discussed, as well as implications of its modification and new strategies to affect Notch3 signaling activity. © AlphaMed Press 2018.

Entities:  

Keywords:  CADASIL; Cancer; Notch3; Tumor

Mesh:

Substances:

Year:  2018        PMID: 29622701      PMCID: PMC6156186          DOI: 10.1634/theoncologist.2017-0677

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  147 in total

1.  Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.

Authors:  Dimitrios Krikelis; Vassiliki Kotoula; Mattheos Bobos; Elena Fountzilas; Konstantinos Markou; Ilias Karasmanis; Nikolaos Angouridakis; Konstantinos Vlachtsis; Konstantine T Kalogeras; Angelos Nikolaou; George Fountzilas
Journal:  Anticancer Res       Date:  2014-11       Impact factor: 2.480

2.  The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium.

Authors:  M Lardelli; J Dahlstrand; U Lendahl
Journal:  Mech Dev       Date:  1994-05       Impact factor: 1.882

3.  A truncated-Flt1 isoform of breast cancer cells is upregulated by Notch and downregulated by retinoic acid.

Authors:  Belén Mezquita; Jovita Mezquita; Carme Barrot; Silvia Carvajal; Montserrat Pau; Pau Mezquita; Cristóbal Mezquita
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

4.  Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.

Authors:  Mohammed Tanjimur Rahman; Kentaro Nakayama; Munmun Rahman; Hiroshi Katagiri; Atsuko Katagiri; Tomoka Ishibashi; Masako Ishikawa; Kouji Iida; Satoru Nakayama; Yoshiro Otsuki; Kohji Miyazaki
Journal:  Am J Clin Pathol       Date:  2012-10       Impact factor: 2.493

5.  Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma.

Authors:  Syed A Ali; Verline Justilien; Lee Jamieson; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2016-03-14       Impact factor: 31.743

6.  Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cells.

Authors:  Joel T Adler; Daniel G Hottinger; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

7.  Notch3 inhibits epithelial-mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells.

Authors:  X Zhang; X Liu; J Luo; W Xiao; X Ye; M Chen; Y Li; G-J Zhang
Journal:  Oncogenesis       Date:  2016-11-14       Impact factor: 7.485

8.  Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice.

Authors:  D Bellavia; A F Campese; E Alesse; A Vacca; M P Felli; A Balestri; A Stoppacciaro; C Tiveron; L Tatangelo; M Giovarelli; C Gaetano; L Ruco; E S Hoffman; A C Hayday; U Lendahl; L Frati; A Gulino; I Screpanti
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

9.  Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways.

Authors:  Gillian Farnie; Robert B Clarke; Katherine Spence; Natasha Pinnock; Keith Brennan; Neil G Anderson; Nigel J Bundred
Journal:  J Natl Cancer Inst       Date:  2007-04-18       Impact factor: 13.506

10.  Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer.

Authors:  K Eto; H Kawakami; M Kuwatani; T Kudo; Y Abe; S Kawahata; A Takasawa; M Fukuoka; Y Matsuno; M Asaka; N Sakamoto
Journal:  Br J Cancer       Date:  2013-03-14       Impact factor: 7.640

View more
  12 in total

1.  Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview.

Authors:  Orlandric Miree; Sanjeev Kumar Srivastava; Santanu Dasgupta; Seema Singh; Rodney Rocconi; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Lung Adenocarcinoma Cells Promote Self-Migration and Self-Invasion by Activating Neutrophils to Upregulate Notch3 Expression of Cancer Cells.

Authors:  Weidong Peng; Youjing Sheng; Han Xiao; Yuanzi Ye; Louis Boafo Kwantwi; Lanqing Cheng; Yuanchong Wang; Jiegou Xu; Qiang Wu
Journal:  Front Mol Biosci       Date:  2022-01-18

3.  Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosis.

Authors:  Ditte Starberg Jespersen; Anna A Schönherz; Hanne Due; Martin Bøgsted; Teis Esben Sondergaard; Karen Dybkær
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

4.  Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis.

Authors:  Yao Yao; Xinyuan Chen; Hong Yang; Wei Chen; Yichun Qian; Zhongyi Yan; Tian Liao; Weiping Yao; Wenlan Wu; Tonghua Yu; Yun Chen; Yuan Zhang
Journal:  J Exp Clin Cancer Res       Date:  2019-07-19

Review 5.  The Role of DLLs in Cancer: A Novel Therapeutic Target.

Authors:  Meng-Xi Xiu; Yuan-Meng Liu; Bo-Hai Kuang
Journal:  Onco Targets Ther       Date:  2020-05-07       Impact factor: 4.147

Review 6.  Role of Notch Receptors in Hematologic Malignancies.

Authors:  Laura Gragnani; Serena Lorini; Silvia Marri; Anna Linda Zignego
Journal:  Cells       Date:  2020-12-24       Impact factor: 6.600

7.  Autoantibody Formation and Mapping of Immunogenic Epitopes against Cold-Shock-Protein YB-1 in Cancer Patients and Healthy Controls.

Authors:  Ronnie Morgenroth; Charlotte Reichardt; Johannes Steffen; Stefan Busse; Ronald Frank; Harald Heidecke; Peter R Mertens
Journal:  Cancers (Basel)       Date:  2020-11-25       Impact factor: 6.639

8.  Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome.

Authors:  Kexin Yan; Yutao Wang; Yuxiu Lu; Zhangyong Yan
Journal:  J Immunol Res       Date:  2021-03-08       Impact factor: 4.818

9.  Regulation of Pain Genes-Capsaicin vs Resiniferatoxin: Reassessment of Transcriptomic Data.

Authors:  Rajeev K Singla; Adiba Sultana; Md Shahin Alam; Bairong Shen
Journal:  Front Pharmacol       Date:  2020-10-29       Impact factor: 5.810

10.  A third Notch in colorectal cancer progression and metastasis.

Authors:  Ute Koch; Freddy Radtke
Journal:  J Exp Med       Date:  2020-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.